BOSTON, Sept 5 (Reuters) - Amgen Inc and Roche Holding AG laid out opening arguments on Wednesday in a trial that will determine whether Roche can sell its anemia drug Mircera in the United States to ...
Roche Holding AG was barred by an appeals court on Friday from selling the anemia drug Mircera in the United States, after a judge found that the company infringes Amgen Inc.’s patents. The U.S. Court ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results